LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Canertinib | 0.04 | uM | LJP6 | 72 | hr | 1694 | 9108 | 11217 | 0.8121 | 0.8530 |
MCF 10A | Canertinib | 0.12 | uM | LJP6 | 72 | hr | 1694 | 6493 | 11217 | 0.5791 | 0.6362 |
MCF 10A | Canertinib | 0.37 | uM | LJP6 | 72 | hr | 1694 | 4255 | 11217 | 0.3795 | 0.4012 |
MCF 10A | Canertinib | 1.11 | uM | LJP6 | 72 | hr | 1694 | 2738 | 11217 | 0.2443 | 0.1916 |
MCF 10A | Canertinib | 3.33 | uM | LJP6 | 72 | hr | 1694 | 2228 | 11217 | 0.1987 | 0.1055 |
MCF 10A | Canertinib | 10 | uM | LJP6 | 72 | hr | 1694 | 115 | 11217 | 0.0103 | -0.6274 |
MCF 10A | NVP-AEW541 | 0.04 | uM | LJP5 | 72 | hr | 1694 | 10983 | 11103 | 0.9892 | 0.9920 |
MCF 10A | NVP-AEW541 | 0.12 | uM | LJP5 | 72 | hr | 1694 | 10777 | 11103 | 0.9706 | 0.9781 |
MCF 10A | NVP-AEW541 | 0.37 | uM | LJP5 | 72 | hr | 1694 | 10089 | 11103 | 0.9086 | 0.9305 |
MCF 10A | NVP-AEW541 | 1.11 | uM | LJP5 | 72 | hr | 1694 | 8455 | 11103 | 0.7614 | 0.8086 |
MCF 10A | NVP-AEW541 | 3.33 | uM | LJP5 | 72 | hr | 1694 | 8576 | 11103 | 0.7724 | 0.8183 |
MCF 10A | NVP-AEW541 | 10 | uM | LJP5 | 72 | hr | 1694 | 5107 | 11103 | 0.4600 | 0.5019 |
MCF 10A | PHA-665752 | 0.04 | uM | LJP5 | 72 | hr | 1694 | 11057 | 11103 | 0.9958 | 0.9969 |
MCF 10A | PHA-665752 | 0.12 | uM | LJP5 | 72 | hr | 1694 | 10792 | 11103 | 0.9720 | 0.9791 |
MCF 10A | PHA-665752 | 0.37 | uM | LJP5 | 72 | hr | 1694 | 10794 | 11103 | 0.9721 | 0.9792 |
MCF 10A | PHA-665752 | 1.11 | uM | LJP5 | 72 | hr | 1694 | 10464 | 11103 | 0.9424 | 0.9567 |
MCF 10A | PHA-665752 | 3.33 | uM | LJP5 | 72 | hr | 1694 | 10469 | 11103 | 0.9428 | 0.9570 |
MCF 10A | PHA-665752 | 10 | uM | LJP5 | 72 | hr | 1694 | 9302 | 11103 | 0.8378 | 0.8737 |
MCF 10A | PI103 | 0.04 | uM | LJP6 | 72 | hr | 1694 | 11606 | 11217 | 1.0346 | 1.0249 |
MCF 10A | PI103 | 0.12 | uM | LJP6 | 72 | hr | 1694 | 11398 | 11217 | 1.0162 | 1.0118 |
MCF 10A | PI103 | 0.37 | uM | LJP6 | 72 | hr | 1694 | 7232 | 11217 | 0.6445 | 0.7015 |
MCF 10A | PI103 | 1.11 | uM | LJP6 | 72 | hr | 1694 | 3253 | 11217 | 0.2899 | 0.2694 |
MCF 10A | PI103 | 3.33 | uM | LJP6 | 72 | hr | 1694 | 2550 | 11217 | 0.2273 | 0.1617 |
MCF 10A | PI103 | 10 | uM | LJP6 | 72 | hr | 1694 | 2227 | 11217 | 0.1985 | 0.1048 |
MCF 10A | Dovitinib | 0.04 | uM | LJP5 | 72 | hr | 1694 | 10366 | 11103 | 0.9336 | 0.9500 |